Hematology
Latest News
Delayed umbilical cord clamping improves outcomes in very preterm infants
Delayed clamping reduced risk of death or disability by 17% at 2 years of age.
Conference Coverage
Beta-thalassemia gene therapy achieves lasting transfusion independence
“Seeing the restoration of iron metabolism, it really takes us a step closer to really thinking the term ‘cure’ might truly apply.”
From the Journals
Apixaban outmatches rivaroxaban for VTE in study
These real-world findings may guide selection of initial anticoagulant therapy, according to authors of the paper.
From the Journals
Rivaroxaban’s single daily dose may lead to higher bleeding risk than other DOACs
Corroborating previous studies, Iceland researchers report that rivaroxaban poses the highest risk of GI bleeding, compared with other DOACs.
From the Journals
Intracranial hemorrhaging a high risk for patients with hemophilia, especially neonates
From the Journals
Study gives bleeding risk estimates for VTE patients on anticoagulants
New research provides best available estimates of long-term bleeding risk with different anticoagulants, authors say.
From the Journals
Sickle cell disease, trait may up risk for poor COVID outcomes
Even those who carry just one copy of the sickle cell gene – the carrier status for sickle cell disease – appeared to be at heightened risk.
From the Journals
Infusion centers may best EDs for treating sickle cell crises
At infusion centers, patients received pain medication an average of 70 minutes faster compared with patients treated in EDs.
From the Journals
First year of life sees initial bleeding episodes in children with von Willebrand disease
Conference Coverage
Venetoclax shows activity against T-ALL in children
Conference Coverage
Sex differences in pediatric B-ALL outcomes persist